Holen Sie sich die Stockscreener-App
8.50
1.43%
0.12
Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten
Forte Biosciences reports annual meeting results - Investing.com
Forte Biosciences Elects New Directors at Annual Meeting - TipRanks
Forte Biosciences reports annual meeting results By Investing.com - Investing.com UK
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World
How the (FBRX) price action is used to our Advantage - news.stocktradersdaily.com
Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
Pre-market Movers: HCTI, PTIX, BCLI, AFMD... - RTTNews
Top Premarket Decliners - marketscreener.com
Forte Biosciences Reports Increased Losses Amid R&D Expansion - TipRanks
Forte Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Forte Biosciences Q1 Operating Expenses USD 16.124 Million - marketscreener.com
Forte Biosciences (FBRX) Advances Trials for FB102 in Celiac Disease and Vitiligo | FBRX Stock News - GuruFocus
Forte Biosciences reports Q1 EPS ($1.37), consensus (95c) - TipRanks
Forte Biosciences, Inc. Announces Results and Provides Update - Eagle-Tribune
Forte Biosciences Q1: Celiac Disease Trial Results Imminent, New Vitiligo Study Launches - Stock Titan
Stock Traders Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World
Forte Biosciences (FBRX) Expected to Announce Earnings on Monday - Defense World
JPMorgan Chase & Co. Trims Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World
Royal Bank of Canada Has Lowered Expectations for Zimmer Biomet (NYSE:ZBH) Stock Price - Defense World
JPMorgan Chase & Co. Buys New Holdings in Innovator U.S. Equity Accelerated ETF – January (BATS:XDJA) - Defense World
(FBRX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Geode Capital Management LLC Boosts Stock Position in AmpliTech Group, Inc. (NASDAQ:AMPG) - Defense World
Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World
Geode Capital Management LLC Increases Position in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World
Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte Corp - Barchart.com
Meta Doubles Down on AI: Is the Stock Ready to Skyrocket? - The Globe and Mail
Shining a Light on IL-13: Optimizing Moderate-to-Severe Atopic Dermatitis Treatment in Daily Practice - Healio
Forte Biosciences sets Annual Meeting for May 29 By Investing.com - Investing.com Canada
Forte Biosciences sets Annual Meeting for May 29 - Investing.com Australia
Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World
Mr. Ethan Billings recommends paying close attention to biotech stocks - FinancialContent
Profit from Trump’s Tariff Playbook with TipRanks’ New Comparison Tool - The Globe and Mail
Nvidia and Broadcom Helped Propel This ETF 18% Higher in a Single Day. Here's Why It's Still a Buy Now. - The Globe and Mail
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Analysts Issue Forecasts for FBRX Q2 Earnings - Defense World
Equities Analysts Offer Predictions for FBRX FY2025 Earnings - Defense World
(FBRX) Investment Analysis - news.stocktradersdaily.com
All You Need to Know About Forte Biosciences (FBRX) Rating Upgrade to Buy - MSN
Forte Biosciences (NASDAQ:FBRX) Given New $61.00 Price Target at Chardan Capital - The AM Reporter
Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World
Chardan Capital Issues Pessimistic Forecast for Forte Biosciences (NASDAQ:FBRX) Stock Price - Defense World
Chardan Adjusts Price Target on Forte Biosciences to $61 From $64, Maintains Buy Rating - MarketScreener
Forte Biosciences Reports 2024 Progress and Financials - TipRanks
Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans? - Yahoo
Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest - Stock Titan
Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Bluefield Daily Telegraph
Forte Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Forte Biosciences Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - MarketScreener
Forte Biosciences, Inc. SEC 10-K Report - TradingView
Forte Biosciences Inc. (FBRX) reports earnings - Quartz
(FBRX) Long Term Investment Analysis - news.stocktradersdaily.com
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
1.89%
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):